Product
AGALSIDASE BETA
1 clinical trial
1 indication
Indication
Fabry's DiseaseClinical trial
A Study to Investigate Safety and Tolerability of Higher Infusion Rate to shORten the duraTion of FabrazymE InfusionStatus: Recruiting, Estimated PCD: 2025-10-06